Literature DB >> 15645162

Beneficial effect of atypical antipsychotics on prefrontal brain function in acute psychotic disorders.

Ann-Christine Ehlis1, Jürgen Zielasek, Martin J Herrmann, Thomas Ringel, Christian Jacob, Andreas J Fallgatter.   

Abstract

Disturbance of prefrontal brain functions is assumed to be responsible for prominent psychopathological symptoms in psychotic disorders. Treatment with atypical, in contrast to typical antipsychotics is considered as a possible strategy for an improvement of prefrontal brain function. In the present study, response control as a specific prefrontal brain function was assessed by means of the Nogo-anteriorization (NGA) derived from the event-related potentials elicited during a Go-NoGo task in a consecutive sample of 39 patients suffering from acute psychotic disorders (brief psychotic disorders, 298.8, n = 34 and schizoaffective disorders, 295.70, n = 5; cycloid psychoses according to the Leonhard classification). A highly significant positive correlation between the amount of antipsychotic medication in terms of chlorpromazine equivalents per day and the NGA as a measure of prefrontal response control was only found in the subgroup of patients treated exclusively or predominantly with atypical antipsychotics but not for those treated with typical antipsychotics. These results are in line with the notion that atypical antipsychotics may exert a beneficial effect on prefrontal brain function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645162     DOI: 10.1007/s00406-005-0562-1

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  54 in total

1.  The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding.

Authors:  M Abbruzzese; S Ferri; S Scarone
Journal:  Neuropsychologia       Date:  1997-06       Impact factor: 3.139

2.  Reference-free identification of components of checkerboard-evoked multichannel potential fields.

Authors:  D Lehmann; W Skrandies
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1980-06

3.  The effect of risperidone on cognition in patients with schizophrenia.

Authors:  E Stip; I Lussier
Journal:  Can J Psychiatry       Date:  1996-10       Impact factor: 4.356

4.  Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain.

Authors:  R D Pascual-Marqui; C M Michel; D Lehmann
Journal:  Int J Psychophysiol       Date:  1994-10       Impact factor: 2.997

5.  Does cognitive function improve with quetiapine in comparison to haloperidol?

Authors:  Dawn I Velligan; John Newcomer; Joseph Pultz; John Csernansky; Anne L Hoff; Roderick Mahurin; Alexander L Miller
Journal:  Schizophr Res       Date:  2002-01-15       Impact factor: 4.939

6.  Intermanual coordination in relation to different clinical subgroups in right-handed patients with schizophrenic and other psychotic disorders.

Authors:  Inge Gorynia; Vincent Campman; Ralf Uebelhack
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2003-02       Impact factor: 5.270

7.  Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia.

Authors:  Dieter F Braus; Gabriele Ende; Wolfgang Weber-Fahr; Traute Demirakca; Heike Tost; Fritz A Henn
Journal:  Eur Neuropsychopharmacol       Date:  2002-04       Impact factor: 4.600

8.  Evidence for unaltered brain electrical topography during prefrontal response control in cycloid psychoses.

Authors:  Ann-Christine Ehlis; Jürgen Zielasek; Martin J Herrmann; Thomas Ringel; Christian Jacob; Annika Wagener; Andreas J Fallgatter
Journal:  Int J Psychophysiol       Date:  2005-02       Impact factor: 2.997

9.  Course and outcome of first-admitted patients with acute and transient psychotic disorders (ICD-10:F23). Focus on relapses and social adjustment.

Authors:  M Jäger M D; M Hintermayr; R Bottlender; A Strauss; H-J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2003-08       Impact factor: 5.270

10.  Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.

Authors:  B Gallhofer; U Bauer; S Lis; S Krieger; H Gruppe
Journal:  Eur Neuropsychopharmacol       Date:  1996       Impact factor: 4.600

View more
  2 in total

1.  Cognitive predictors of skill acquisition on social problem solving in patients with schizophrenia.

Authors:  Alp Uçok; Sibel Cakir; Zekiye Cetinkaya Duman; Aysun Dişcigil; Pinar Kandemir; Hatice Atli
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

Review 2.  Cycloid psychosis: an examination of the validity of the concept.

Authors:  Victor Peralta; Manuel J Cuesta; Maria Zandio
Journal:  Curr Psychiatry Rep       Date:  2007-06       Impact factor: 5.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.